{"url_path":"/sec/vani/8-k/2026-07-07/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-07","source_url":"https://www.sec.gov/Archives/edgar/data/1266806/0001753926-26-001144-index.html","accession_number":"0001753926-26-001144","cik":"0001266806","ticker":"VANI","issuer_name":"Vivani Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1266806/0001753926-26-001144-index.html","primary_entity_key":"0001266806","primary_entity_name":"Vivani Medical, Inc."},"word_count":104,"has_tables":true,"body_markdown":"Item 9.01. Financial Statements and Exhibits.\n\n \n\n(d) Exhibits.\n\n        \n\nExhibit No.\n\nDescription\n\n[2.1](ex21_1.htm)\n\n \n\n[Agreement and Plan of Merger dated July 1, 2026 by and among Vivani Medical, Inc., Cortigent, Inc., ClearOne, Inc. and CLRO Merger Sub, Inc.](ex21_1.htm)\n\n[99.1](ex991_2.htm)\n\n \n\n[Press release dated July 7, 2026.](ex991_2.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document). \n\n \n\nSIGNATURES\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nVIVANI MEDICAL, INC.\n\n \n\n \n\n \n\nDate: July 7, 2026\n\nBy:\n\n/s/ Donald Dwyer\n\n \n\nName:\n\nDonald Dwyer\n\n \n\nTitle:\n\nChief Business Officer"}